Imipenem versus targeted therapy in cancer patients

International Journal of Antimicrobial Agents

Volumn 10, Issue 4, 1998, Pages 263-270

  Aoun, M ^a   Crokaert, F ^a   Paesmans, M ^a   Autier, P ^b   Klastersky, J ^a  

^a JULES BORDET INSTITUTE   (Belgium)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Imipenem; Non neutropenic cancer patients; Severe infections; Targeted therapy

Indexed keywords

AMIKACIN; CIPROFLOXACIN; IMIPENEM; METRONIDAZOLE; OXACILLIN; PENICILLIN G;

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CANCER PATIENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COST; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUPERINFECTION;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; FEVER; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; IMIPENEM; MYCOSES; NEOPLASMS; NEUTROPENIA; THIENAMYCINS;

EID: 0032434160     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(98)00055-7     Document Type: Article

References (13)

1. Bodey GP, Jadeja L, Elting L Pseudomonas bacteremia. Arch Intern Med. 145:1985;1621-1629.
2. Schimpff SC. Infections in the cancer patient-diagnosis, prevention and treatment. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases 4th ed. New York: Churchill-Livingstone, 1995:2666-2675.
3. Neu H.C. Carbapenems: special properties contributing to their activity. Am J Med 1985;78 Suppl 6A:33-40.
4. Finegold SM. Anaerobic bacteria: general concepts. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases 4th ed. New York: Churchill-Livingstone, 1995:2156-2173.
5. Detsky AS, Naglie IG A clinician guide to cost-effectiveness. Ann Intern Med. 113:1990;147-154.
6. Institut National d'Assurance Maladie-Invalidité (Belgique). Liste des Médicaments Remboursables, Bruxelles, 1992, Révision 1995.
7. Bodey GP. Infection in cancer patients. Am J Med 1986;81 Suppl 1A:11-26.
8. Rolston K, Bolivar R, Fainstein V, Jones P, Elting L, Bodey GP Cefotaxime: single agent therapy for infections in cancer patients with adequate granulocyte counts. J Antimicrob Chemother. 15:1985;91-96.
9. Bodey GP, Alvarez ME, Jones PG, Rolston KV, Steelhammer L, Fainstein V Imipenem-cilastatin as initial therapy for febrile cancer patients. Antimicrob Ag Chemother. 30:1986;211-214.
10. Winston DJ, McGrattan MA, Busuttil RW Imipenem therapy of Pseudomonas aeruginosa and other serious bacterial infections. Antimicrob Ag Chemother. 26:1984;673-677.
11. Norrby SR, Rogers FD, Ferber F Disposition of radiolabeled imipenem and cilastatin in normal human volunteers. Antimicrob Ag Chemother. 26:1984;707-714.
12. Rolston KVI, Berkey P, Bodey GP A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients. Arch Intern Med. 152:1992;283-291.
13. Kardori N, Elting L, Wong E, Schable B, Bodey GP Nosocomial Infections due to Xanthomonas maltophilia (Pseudomonas maltophilia) in patients with cancer. Rev Infect Dis. 12:1990;997-1003.